Regional anesthesia and anticoagulation

Journal of Clinical Anesthesia

Volumn 13, Issue 1, 2001, Pages 49-58

  Wu, Christopher L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Anesthesia, regional; Anticoagulation; Hematoma; Heparin, warfarin

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULATION; EPIDURAL CATHETER; HEMATOMA; HUMAN; PRIORITY JOURNAL; REGIONAL ANESTHESIA; REVIEW;

ANESTHESIA, CONDUCTION; ANTICOAGULANTS; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 0035099085     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(00)00225-7     Document Type: Review

References (55)

1. Vandermeulen EP, Van Aken H, Vermylen J: Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994;79:1165-77.
2. Tryba M: Epidural regional anesthesia and low molecular heparin: Pro. Anasthesiol Intensivmed Notfallmed Schmerzther 1993;28: 179-81.
3. Liu S, Carpenter RL, Neal JM: Epidural anesthesia and analgesia. Their role in postoperative outcome. Anesthesiology 1995;82:1474-506.
4. Schafer AI: Antiplatelet therapy. Am J Med 1996;101:199-209.
5. Patrono C: Aspirin as an antiplatelet drug. N Engl J Med 1994; 330:1287-94.
6. Hirsh J, Dalen JE, Fuster V, Harker LB, Patrono C, Roth G: Aspirin and other platelet-active drugs. Their relationship among dose, effectiveness, and side effects. Chest 1995;108(4 Suppl): 247S-57S.
7. Roth GJ, Calverlly DC: Aspirin, platelets, and thrombosis: theory and practice. Blood 1994;83:885-98.
8. Schrör K: Antiplatelet drugs. A comparative review. Drugs 1995; 50:7-28.
9. Schafer AI: Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med 1999;106(5B):25S-36S.
10. Dabaghi SF, Kamat SG, Payne J, et al: Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects. Am J Cardiol 1994;74:720-3.
11. Patrignani P, Filabozzi P, Patrono C: Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982;69:1366-72.
12. Patrono C, Coller B, Dalen JE, et al: Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 1998;114(5 Suppl):470S-88S.
13. Schafer AI: Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995; 35:209-19.
14. Leese PT, Hubbard RC, Karim A, Isakson PC, Yu SS, Geis GS: Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 2000;40:124-32.
15. Simon LS, Lanza FL, Lipsky PE, et al: Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum 1998;41:1591-602.
16. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H: Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108(4 Suppl):231S-46S.
17. Holford NH: Clinical pharmacokinetics and pharmacodynamics of warfarin: understanding the dose-effect relationship. Clin Pharmacokinet 1986;11:483-504.
18. Zivelin A, Rao LV, Rapaport SI: Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors. J Clin Invest 1993;92:2131-40.
19. Giles AR, Tinlin S, Brosseau L, Hoogendoorn H: In vivo studies of the role of factor VII in hemostasis. Blood 1985;65:1197-200.
20. Solanki DL, Corn M: Thromboembolism in patients with hereditary deficiency of coagulation factors. South Med J 1980;73:944-6.
21. Mariani G, Lo Coco L, Bernardi F, Pinotti M: Molecular and clinical aspects of factor VII deficiency. Blood Coagul Fibrinolysis 1998;9:S83-8.
22. Enneking FK, Benzon H: Oral anticoagulants and regional anesthesia: a perspective. Reg Anesth Pain Med 1998;23(6 Suppl 2):140-5.
23. Rosenquist RW, Brown DL: Neuraxial bleeding: fibrinolytics/ thrombolytics. Reg Anesth Pain Med 1998;23(Suppl 2):152-6.
24. Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L: Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1995;108(4 Suppl):258S-75S.
25. Hirsh J, Levine MN: Low molecular weight heparin. Blood 1992; 79:1-17.
26. Liu SS, Mulroy MF: Neuraxial anesthesia and analgesia in the presence of standard heparin. Reg Anesth Pain Med 1998;23(Suppl 2):157-63.
27. Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE: Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1998;114(5 Suppl):489-510S.
28. Horlocker TT, Heit JA: Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg 1997;85:874-85.
29. Kitchen S, Iampietro R, Wooley AM, Preston FE: Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability. Thromb Haemost 1999;82: 1289-93.
30. Horlocker TT, Wedel DJ, Schroeder DR, et al: Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg 1995;80: 303-9.
31. Horlocker TT, Wedel DJ, Offord KP: Does preoperative antiplatelet therapy increase the risk of hemorrhagic complications associated with regional anesthesia? Anesth Analg 1990;70:631-4.
32. CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-Dose Aspirin Study in Pregnancy). Lancet 1994;343:619-29.
33. Sibai BM, Caritis SN, Thorn E, Shaw K, McNellis D: Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network. Am J Obstet Gynecol 1995;172:1553-7.
34. Wu CL, Perkins FM: Oral anticoagulant prophylaxis and epidural catheter removal. Reg Anesth 1996;21:517-24.
35. Tcheng JE: Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment. Am Heart J 2000; 139:S38-45.
36. Urmey WF, Rowlingson J: Do antiplatelet agents contribute to the development of perioperative spinal hematoma? Reg Anesth Pain Med 1998; 23 (6 Suppl 2): 146-51.
37. O'Kelly SW, Lawes EG, Luntley JB: Bleeding time: is it a useful clinical tool? Br J Anaesth 1992;68:313-5.
38. Bick RL: Laboratory evaluation of platelet dysfunction. Clin Lab Med 1995;15:1-38.
39. Horlocker TT, Wedel DJ, Schlichting JL: Postoperative epidural analgesia and oral anticoagulant therapy. Anesth Analg 1994;79: 89-93.
40. Odoom JA, Sih IL: Epidural analgesia and anticoagulant therapy. Experience with one thousand cases of continuous epidurals. Anaesthesia 1983;38:254-9.
41. Gurewich V, Nunn T, Kuriakose TT, Hume M: Hemostatic effects of uniform, low-dose subcutaneous heparin in surgical patients. Arch Intern Med 1978;138:41-4.
42. Gallus AS, Hirsh J, Tuttle RJ, et al: Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 1973;288:545-51.
43. Cooke ED, Lloyd MJ, Bowcock SA, Pilcher MF: Monitoring during low-dose heparin prophylaxis. N Engl J Med 1976;294: 1066-7.
44. Baron HC, LaRaja RD, Rossi G, Atkinson D: Continuous epidural analgesia in the heparinized vascular surgical patient: a retrospective review of 912 patients. J Vasc Surg 1987;6:144-6.
45. Rao TL, El-Etr AA: Anticoagulation following placement of epidural and subarachnoid catheters: an evaluation of neurologic sequelae. Anesthesiology 1981;55:618-20.
46. Ruff RL, Dougherty JH Jr: Complications of lumbar puncture followed by anticoagulation. Stroke 1981;12:879-81.
47. Tryba M, Wedel DJ: Central neuraxial block and low molecular heparin (enoxaparine): lessons learned from different dosage regimes in two continents. Acta Anaesthesiol Scand (Suppl) 1997; 111:100-4.
48. Horlocker TT, Wedel DJ: Neuraxial block and low-molecular-weight heparin: balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med 1998;23(6 Suppl 2):164-77.
49. Bergqvist D, Lindblad B, Matzsch T: Risk of combining low molecular weight heparin for thromboprophylaxis and epidural or spinal anesthesia. Semin Thromb Haemost 1993;19(Suppl 1): 147-51.
50. Bergqvist D, Lindblad B, Matzsch T: Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia - is there a risk? Acta Anaesthesiol Scand 1992;36:605-9.
51. Tryba M: European practice guidelines: thromboembolism prophylaxis and regional anesthesia. Reg Anesth Pain Med 1998;23(6 Suppl 2):178-82.
52. Lindgren L, Silvanto M, Scheinin B, Kauste A, Rosenberg PH: Erythrocyte counts in the cerebrospinal fluid associated with continuous spinal anaesthesia. Acta Anaesthesiol Scand 1995;39: 396-400.
53. Schroeder DR: Statistics: detecting a rare adverse drug reaction using spontaneous reports. Reg Anesth Pain Med 1998;23(6 Suppl 2):183-9.
54. Foo D, Rossier AB: Preoperative neurological status in predicting surgical outcome of spinal epidural hematomas. Surg Neurol 1981;15:389-401.
55. Hawkins JL, Koonin LM, Palmer SK, Gibbs CP: Anesthesia-related deaths during obstetric delivery in the United States, 1979-1990. Anesthesiology 1997:86:277-84.